Merit Medical Systems (MMSI) Expected to Announce Quarterly Earnings on Thursday

Merit Medical Systems (NASDAQ:MMSI) is expected to release its Q1 2026 results after the market closes on Thursday, April 30th. Analysts expect Merit Medical Systems to post earnings of $1.07 per share and revenue of $409.3950 million for the quarter. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Parties can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Thursday, April 30, 2026 at 4:30 PM ET.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Tuesday, February 24th. The medical instruments supplier reported $1.04 EPS for the quarter, topping the consensus estimate of $0.96 by $0.08. The company had revenue of $393.94 million for the quarter, compared to the consensus estimate of $390.77 million. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.Merit Medical Systems’s quarterly revenue was up 10.9% on a year-over-year basis. During the same period last year, the business posted $0.93 EPS. On average, analysts expect Merit Medical Systems to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Merit Medical Systems Trading Down 1.7%

Shares of NASDAQ MMSI opened at $67.43 on Tuesday. Merit Medical Systems has a twelve month low of $66.34 and a twelve month high of $100.19. The company has a quick ratio of 2.95, a current ratio of 4.34 and a debt-to-equity ratio of 0.46. The business has a fifty day simple moving average of $71.61 and a two-hundred day simple moving average of $80.05. The firm has a market cap of $4.02 billion, a PE ratio of 31.81, a price-to-earnings-growth ratio of 1.93 and a beta of 0.64.

Institutional Trading of Merit Medical Systems

Several hedge funds have recently modified their holdings of the company. CIBC Asset Management Inc bought a new position in shares of Merit Medical Systems during the 4th quarter worth approximately $294,000. Graham Capital Management L.P. boosted its stake in Merit Medical Systems by 23.6% in the fourth quarter. Graham Capital Management L.P. now owns 3,324 shares of the medical instruments supplier’s stock valued at $293,000 after acquiring an additional 635 shares in the last quarter. Occudo Quantitative Strategies LP acquired a new stake in Merit Medical Systems in the second quarter valued at approximately $292,000. Cerity Partners LLC grew its holdings in Merit Medical Systems by 9.1% in the second quarter. Cerity Partners LLC now owns 3,019 shares of the medical instruments supplier’s stock worth $282,000 after purchasing an additional 251 shares during the last quarter. Finally, PharVision Advisers LLC purchased a new position in Merit Medical Systems in the third quarter worth $265,000. 99.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently weighed in on MMSI shares. Needham & Company LLC restated a “buy” rating and issued a $101.00 price objective on shares of Merit Medical Systems in a report on Wednesday, April 1st. Piper Sandler cut their target price on shares of Merit Medical Systems from $106.00 to $96.00 and set an “overweight” rating on the stock in a research report on Friday, April 17th. Barrington Research lowered their price target on shares of Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating for the company in a research report on Monday, April 20th. Compass Point set a $107.00 price objective on shares of Merit Medical Systems in a research note on Monday, April 20th. Finally, Canaccord Genuity Group cut their price objective on shares of Merit Medical Systems from $99.00 to $90.00 and set a “buy” rating on the stock in a report on Tuesday, April 7th. Seven investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Merit Medical Systems currently has an average rating of “Moderate Buy” and a consensus target price of $99.56.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.